Insider Transactions in Q1 2022 at Hca Healthcare, Inc. (HCA)
Insider Transaction List (Q1 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 11
2022
|
Joseph A Sowell Iii SVP; Chief Development Officer |
SELL
Open market or private sale
|
Direct |
11,522
-40.32%
|
$3,099,418
$269.0 P/Share
|
|
Feb 18
2022
|
Jennifer Berres SVP & Chief Human Res. Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,827
-17.05%
|
$689,788
$244.1 P/Share
|
|
Feb 18
2022
|
Jennifer Berres SVP & Chief Human Res. Officer |
BUY
Grant, award, or other acquisition
|
Direct |
8,720
+23.38%
|
-
|
|
Feb 18
2022
|
Phillip G Billington SVP-Internal Audit Services |
SELL
Payment of exercise price or tax liability
|
Direct |
1,224
-2.93%
|
$298,656
$244.1 P/Share
|
|
Feb 18
2022
|
Phillip G Billington SVP-Internal Audit Services |
BUY
Grant, award, or other acquisition
|
Direct |
4,640
+10.0%
|
-
|
|
Feb 18
2022
|
Jeffrey E. Cohen SVP-Government Relations |
SELL
Payment of exercise price or tax liability
|
Direct |
1,634
-35.22%
|
$398,696
$244.1 P/Share
|
|
Feb 18
2022
|
Jeffrey E. Cohen SVP-Government Relations |
BUY
Grant, award, or other acquisition
|
Direct |
4,640
+50.0%
|
-
|
|
Feb 18
2022
|
Michael S. Cuffe EVP and Chief Clinical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,658
-12.7%
|
$892,552
$244.1 P/Share
|
|
Feb 18
2022
|
Michael S. Cuffe EVP and Chief Clinical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
10,840
+27.35%
|
-
|
|
Feb 18
2022
|
Jon M Foster EVP and COO |
SELL
Payment of exercise price or tax liability
|
Direct |
6,082
-35.73%
|
$1,484,008
$244.1 P/Share
|
|
Feb 18
2022
|
Jon M Foster EVP and COO |
BUY
Grant, award, or other acquisition
|
Direct |
17,020
+50.0%
|
-
|
|
Feb 18
2022
|
Charles J Hall Group President |
SELL
Payment of exercise price or tax liability
|
Direct |
6,082
-2.93%
|
$1,484,008
$244.1 P/Share
|
|
Feb 18
2022
|
Charles J Hall Group President |
BUY
Grant, award, or other acquisition
|
Direct |
17,020
+7.57%
|
-
|
|
Feb 18
2022
|
Samuel N Hazen CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
35,830
-8.64%
|
$8,742,520
$244.1 P/Share
|
|
Feb 18
2022
|
Samuel N Hazen CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
6,011
+1.43%
|
-
|
|
Feb 18
2022
|
Samuel N Hazen CEO |
BUY
Grant, award, or other acquisition
|
Direct |
85,040
+17.22%
|
-
|
|
Feb 18
2022
|
A Bruce Moore Jr Group President - Service Line |
SELL
Payment of exercise price or tax liability
|
Direct |
3,656
-3.56%
|
$892,064
$244.1 P/Share
|
|
Feb 18
2022
|
A Bruce Moore Jr Group President - Service Line |
BUY
Grant, award, or other acquisition
|
Direct |
10,840
+9.55%
|
-
|
|
Feb 18
2022
|
Sammie S Mosier SVP & Chief Nurse Executive |
SELL
Payment of exercise price or tax liability
|
Direct |
229
-3.44%
|
$55,876
$244.1 P/Share
|
|
Feb 18
2022
|
Sammie S Mosier SVP & Chief Nurse Executive |
BUY
Grant, award, or other acquisition
|
Direct |
940
+12.38%
|
-
|
|
Feb 18
2022
|
P. Martin Paslick SVP and CIO |
SELL
Payment of exercise price or tax liability
|
Direct |
3,046
-13.75%
|
$743,224
$244.1 P/Share
|
|
Feb 18
2022
|
P. Martin Paslick SVP and CIO |
BUY
Grant, award, or other acquisition
|
Direct |
9,280
+29.52%
|
-
|
|
Feb 18
2022
|
Deborah M Reiner SVP - Mktg. & Communications |
SELL
Payment of exercise price or tax liability
|
Direct |
1,223
-13.35%
|
$298,412
$244.1 P/Share
|
|
Feb 18
2022
|
Deborah M Reiner SVP - Mktg. & Communications |
BUY
Grant, award, or other acquisition
|
Direct |
4,640
+33.61%
|
-
|
|
Feb 18
2022
|
Bill B Rutherford CFO and EVP |
SELL
Payment of exercise price or tax liability
|
Direct |
8,821
-10.79%
|
$2,152,324
$244.1 P/Share
|
|
Feb 18
2022
|
Bill B Rutherford CFO and EVP |
BUY
Grant, award, or other acquisition
|
Direct |
23,980
+22.67%
|
-
|
|
Feb 18
2022
|
Joseph A Sowell Iii SVP; Chief Development Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,046
-9.63%
|
$743,224
$244.1 P/Share
|
|
Feb 18
2022
|
Joseph A Sowell Iii SVP; Chief Development Officer |
BUY
Grant, award, or other acquisition
|
Direct |
7,740
+19.67%
|
-
|
|
Feb 18
2022
|
Kathryn A. Torres SVP-Payer Contracting & Align. |
SELL
Payment of exercise price or tax liability
|
Direct |
1,836
-7.58%
|
$447,984
$244.1 P/Share
|
|
Feb 18
2022
|
Kathryn A. Torres SVP-Payer Contracting & Align. |
BUY
Grant, award, or other acquisition
|
Direct |
6,200
+20.39%
|
-
|
|
Feb 18
2022
|
Kathleen M Whalen SVP & Chief Ethics Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,224
-9.35%
|
$298,656
$244.1 P/Share
|
|
Feb 18
2022
|
Kathleen M Whalen SVP & Chief Ethics Officer |
BUY
Grant, award, or other acquisition
|
Direct |
4,640
+26.16%
|
-
|
|
Feb 18
2022
|
Christopher F. Wyatt SVP & Controller |
SELL
Payment of exercise price or tax liability
|
Direct |
1,836
-5.4%
|
$447,984
$244.1 P/Share
|
|
Feb 18
2022
|
Christopher F. Wyatt SVP & Controller |
BUY
Grant, award, or other acquisition
|
Direct |
6,200
+15.42%
|
-
|
|
Feb 17
2022
|
A Bruce Moore Jr Group President - Service Line |
SELL
Open market or private sale
|
Direct |
9,367
-9.26%
|
$2,369,851
$253.18 P/Share
|
|
Feb 16
2022
|
A Bruce Moore Jr Group President - Service Line |
SELL
Open market or private sale
|
Direct |
20,633
-16.94%
|
$5,034,452
$244.01 P/Share
|
|
Feb 09
2022
|
Kathleen M Whalen SVP & Chief Ethics Officer |
SELL
Bona fide gift
|
Direct |
420
-4.73%
|
-
|
|
Feb 03
2022
|
Sammie S Mosier SVP & Chief Nurse Executive |
SELL
Payment of exercise price or tax liability
|
Direct |
34
-0.59%
|
$8,160
$240.86 P/Share
|
|
Feb 03
2022
|
Sammie S Mosier SVP & Chief Nurse Executive |
BUY
Exercise of conversion of derivative security
|
Direct |
137
+2.33%
|
-
|
|
Jan 31
2022
|
Sammie S Mosier SVP & Chief Nurse Executive |
SELL
Payment of exercise price or tax liability
|
Direct |
66
-1.16%
|
$15,840
$240.05 P/Share
|
|
Jan 31
2022
|
Sammie S Mosier SVP & Chief Nurse Executive |
BUY
Exercise of conversion of derivative security
|
Direct |
273
+4.59%
|
-
|
|
Jan 30
2022
|
Sammie S Mosier SVP & Chief Nurse Executive |
SELL
Payment of exercise price or tax liability
|
Direct |
73
-1.33%
|
$17,228
$236.61 P/Share
|
|
Jan 30
2022
|
Sammie S Mosier SVP & Chief Nurse Executive |
BUY
Exercise of conversion of derivative security
|
Direct |
272
+4.73%
|
-
|
|
Jan 29
2022
|
Sammie S Mosier SVP & Chief Nurse Executive |
SELL
Payment of exercise price or tax liability
|
Direct |
96
-1.81%
|
$22,656
$236.61 P/Share
|
|
Jan 29
2022
|
Sammie S Mosier SVP & Chief Nurse Executive |
BUY
Exercise of conversion of derivative security
|
Direct |
323
+5.75%
|
-
|
|
Jan 28
2022
|
Andrea B Smith Director |
BUY
Grant, award, or other acquisition
|
Direct |
177
+50.0%
|
-
|
|
Jan 05
2022
|
Joseph A Sowell Iii SVP; Chief Development Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
11,853
-33.17%
|
$3,058,074
$258.97 P/Share
|
|
Jan 05
2022
|
Joseph A Sowell Iii SVP; Chief Development Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
23,375
+39.55%
|
$1,098,625
$47.97 P/Share
|
|
Jan 04
2022
|
Joseph A Sowell Iii SVP; Chief Development Officer |
SELL
Open market or private sale
|
Direct |
22,198
-64.24%
|
$5,749,282
$259.23 P/Share
|